Table 3.

Length of stay, complications, and outcome of critically ill patients according positivity for anti-IFN-α2 and/or anti-IFN-ω auto-Abs

VariablesTotalPositiveNegativeP value
Length of ICU stay (days), median (IQR) 13 (6–23) 10 (8–12) 13 (6–23) 0.163 
Invasive ventilatory support, n (%) 171 (81.8) 13 (92.8) 158 (81.0) 0.268 
Hemodialysis, n (%) 59 (29.0) 7 (50.0) 52 (27.5) 0.074 
Sepsis, n (%) 44 (21.0) 4 (28.5) 40 (20.5) 0.475 
Shock, n (%) 61 (29.1) 5 (35.7) 56 (28.7) 0.578 
Heart failure, n (%) 7 (3.3) 1 (7.1) 6 (3.0) 0.414 
Death, n (%) 85 (40.8) 8 (57.1) 77 (39.6) 0.200 
VariablesTotalPositiveNegativeP value
Length of ICU stay (days), median (IQR) 13 (6–23) 10 (8–12) 13 (6–23) 0.163 
Invasive ventilatory support, n (%) 171 (81.8) 13 (92.8) 158 (81.0) 0.268 
Hemodialysis, n (%) 59 (29.0) 7 (50.0) 52 (27.5) 0.074 
Sepsis, n (%) 44 (21.0) 4 (28.5) 40 (20.5) 0.475 
Shock, n (%) 61 (29.1) 5 (35.7) 56 (28.7) 0.578 
Heart failure, n (%) 7 (3.3) 1 (7.1) 6 (3.0) 0.414 
Death, n (%) 85 (40.8) 8 (57.1) 77 (39.6) 0.200 

Continuous variables were compared using the Mann–Whitney test. Categorical variables were compared using the chi-square test or Fisher’s exact test when appropriate. ICU: intensive care unit; IQR: interquartile range.

or Create an Account

Close Modal
Close Modal